Table 3.
HPV and HPV vaccine knowledge pre- and post-intervention (n correct / n total (%))
| Healthcare Staff | School Staff | |||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| Number of new HPV cases each year in the USa | 36/115 (31) | 99/116 (85)** | 169/445 (38) | 393/452 (87)** |
| Percent of new HPV cases that occur in 15–24 year oldsa | 69/117 (59) | 111/117 (95)** | 228/446 (51) | 405/454 (89)** |
| Percent of cervical cancers where HPV can be founda | 24/118 (20) | 97/116 (84)** | 54/443 (12) | 311/450 (69)** |
| Vaccine is effective in virus-naïve females but does not protect against or treat existing infections | 90/117 (77) | 113/117 (97)** | 347/443 (78) | 437/449 (97)** |
| Half of cervical cancer cases between ages 35–50 were likely exposed to HPV in teens or early twenties | 113/118 (96) | 117/118 (99) | 408/442 (92) | 443/450 (98)** |
| A woman dies every 2.5 hours from cervical cancer in the US | 91/118 (77) | 103/118 (87)* | -- | -- |
| Regular Pap smear tests are no longer needed after HPV vaccinationb | 115/118 (97) | 117/117 (100) | -- | -- |
Note. Analyses used mixed regression models since participants were clustered within education sessions. Sample sizes differ due to missing data. Dashes (--) indicate item was not assessed.
a
Multiple choice item with responses scored as “correct” or “incorrect”. All other items used a true/false response scale.
b
Correct response was “false”.
*
p<0.05,
**
p<0.001